Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.
Goldman L, Weinstein MC, Goldman PA, Williams LW. Goldman L, et al. Among authors: williams lw. JAMA. 1991 Mar 6;265(9):1145-51. JAMA. 1991. PMID: 1899896
Cost-effectiveness of hypertension therapy according to 2014 guidelines.
Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, Williams L, Bibbins-Domingo K, Coxson PG, Goldman L. Moran AE, et al. N Engl J Med. 2015 Jan 29;372(5):447-55. doi: 10.1056/NEJMsa1406751. N Engl J Med. 2015. PMID: 25629742 Free PMC article.
Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.
Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Pletcher MJ, et al. Ann Intern Med. 2009 Feb 17;150(4):243-54. doi: 10.7326/0003-4819-150-4-200902170-00005. Ann Intern Med. 2009. PMID: 19221376
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Gaspoz JM, et al. Among authors: williams lw. N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Prosser LA, et al. Among authors: williams lw. Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699
Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels.
Tosteson AN, Weinstein MC, Hunink MG, Mittleman MA, Williams LW, Goldman PA, Goldman L. Tosteson AN, et al. Among authors: williams lw. Circulation. 1997 Jan 7;95(1):24-30. doi: 10.1161/01.cir.95.1.24. Circulation. 1997. PMID: 8994412
Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.
Goldman L, Goldman PA, Williams LW, Weinstein MC. Goldman L, et al. Among authors: williams lw. Am J Cardiol. 1993 Sep 30;72(10):75D-79D. doi: 10.1016/0002-9149(93)90015-5. Am J Cardiol. 1993. PMID: 8213502
Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.
Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Weinstein MC, et al. Among authors: williams lw. Am J Public Health. 1987 Nov;77(11):1417-26. doi: 10.2105/ajph.77.11.1417. Am J Public Health. 1987. PMID: 3661794 Free PMC article.
Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model.
Goldman L, Weinstein MC, Williams LW. Goldman L, et al. Among authors: williams lw. Circulation. 1989 Aug;80(2):254-60. doi: 10.1161/01.cir.80.2.254. Circulation. 1989. PMID: 2787708
Long-term impact of smoking cessation on the incidence of coronary heart disease.
Tosteson AN, Weinstein MC, Williams LW, Goldman L. Tosteson AN, et al. Among authors: williams lw. Am J Public Health. 1990 Dec;80(12):1481-6. doi: 10.2105/ajph.80.12.1481. Am J Public Health. 1990. PMID: 2240335 Free PMC article.
78 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback